Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
P
Perspective Therapeutics Inc
AMEX:CATX
Perspective Therapeutics Inc
AMEX:CATX
Price:
2.59
USD
-2.63%
Market Closed
Market Cap:
$295.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Perspective Therapeutics Inc
AMEX:CATX
|
US |
|
B
|
Blessed Assets Group Co Ltd PCL
SET:BLESS
|
TH |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
F:AIL
|
FR |
|
N
|
Newpath Resources Inc
CNSX:PATH
|
CA |
|
T
|
Teixeira Duarte SA
F:TXC2
|
PT |
Wall St Price Targets
CATX Price Forecast
Based on 16 analysts
Based on 16 analysts
+412% Upside
from
$2.59
today
Perspective Therapeutics Inc (CATX)’s 12-month stock price forecast through October 2027 has a consensus target of $13.26, implying 412% upside. The forecast is based on price targets from 16 Wall Street analysts.
Perspective Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CATX's stock price target?
Price Target
13.26
USD
13.26
USD
According to Wall Street analysts, the average 1-year price target for CATX is 13.26 USD with a low forecast of 5.05 USD and a high forecast of 18.9 USD.
What is the Revenue forecast for Perspective Therapeutics Inc?
Projected CAGR
131%
131%
Over the last 2 years, the compound annual growth rate for Revenue has been -21%. The projected CAGR for the next 8 years is 131%.